Steven Cohen Acadia Pharmaceuticals Inc Put Options Transaction History

Point72 Asset Management, L.P.

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q1 2018 May 15, 2018	SELL	$22.47 - $32.33 $2.25 Million - $3.23 Million	-100,000 Reduced 20.0%	400,000 $8.99 Million
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $14.7 Million - $19.2 Million	500,000	500,000 $18.8 Million

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.